Suppression of FAK by nexrutine inhibits gastric cancer progression.
Life Sciences（2020）
Abstract
Nexrutine inhibited the malignant progression of gastric cancer via negatively regulating STAT3/NF-κB signaling pathway by suppressing FAK expression and activation.
MoreTranslated text
Key words
Nexrutine,Gastric cancer,STAT3/NF-κB pathway,FAK
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined